RARRES2 and metabolic dysfunction-associated steatotic liver disease: The results indicate that baseline chemerin quantities were not predictive for weight loss-associated dynamics of body fat percentage (Figure 5A) and liver fibrosis—as was displayed by the NAFLD fibrosis score and FIB4 (Figure 5B,C)—in LCD patients within 12 months.